Skip to content
Scleroderma News logo
  • About scleroderma
    What is scleroderma?
    Causes
    Types
    Diagnosis
    • Skin biopsy
    Symptoms
    Scleroderma-related conditions
    Living with scleroderma
    • Pregnancy
    • Sexual health and dysfunction
  • Treatments
    Approved treatments
    Experimental treatments
    Non-drug treatments
    • Physical therapy
    • Phototherapy
  • News
  • Columns
    Scleroderma: Road Under Construction – Tomisa Starr
    Archived columns
    • Truth Be Told – Sherlene Perkins
    • Chronically Me — Amy Baker
    • Finding Strength — Lisa Weber
    • Scleroderma and the Ordinary Girl — Kim Tocker
    • Skintight — Dinah Chong Watkins
    • Staying Alive With Scleroderma — Amy Gietzen
  • What can we help you find today?

  • Social Clips
  • Last Week’s Top-3 Most Read Posts On Scleroderma

Last Week’s Top-3 Most Read Posts On Scleroderma

admin avatar

by admin | November 16, 2015

Share this article:

Share article via email

news_5-04

Read the Articles Here:

Mycophenolate Mofitil Identified As Promising Scleroderma-Related Interstitial Lung Disease Treatment

Scleroderma Patient with Pulmonary NH Lymphoma Highlights Risk

Systemic Sclerosis Patients’ Intestinal Microbiome Found To Be Enriched by Inflammatory Bacteria

Print This Page

Tags

Intestinal Microbiome, mycophenolate mofitil, Pulmonary NH Lymphoma, top 3

Recent Posts

  • Scleroderma community gears up for awareness month in June
  • Heart fibrosis may contribute to sudden death in systemic sclerosis
  • Ofev consistently slows lung function decline in SSc-ILD: Study
  • Large study IDs risks for primary heart involvement in scleroderma
  • Age, sex, socioeconomics tied to localized scleroderma risk: Study
  • Why those of us with scleroderma need patient-centered care
  • Sex differences confirmed in SSc, with 5 times higher risk for women
  • Exosome-based therapy eases skin scarring in scleroderma mice: Study
  • ALLO-329 gets FDA fast track designation for diffuse scleroderma
  • Finding the ‘Goldilocks zone’ to manage scleroderma, Raynaud’s


Recommended reading

A dial of risk points to HIGH.
May 20, 2025 News by Andrea Lobo, PhD

Heart fibrosis may contribute to sudden death in systemic sclerosis

A bar graph, a pie chart, and a bottle for prescription medication are sandwiched by the words
May 13, 2025 News by Andrea Lobo, PhD

Ofev consistently slows lung function decline in SSc-ILD: Study

A woman smiles and holds herself as her heart is shown beating under her shirt.
May 6, 2025 News by Andrea Lobo, PhD

Large study IDs risks for primary heart involvement in scleroderma

Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.